Corresponding to these two perspectives, we hypothesized that (a) biologically, tau-PET patterns would modulate the association between baseline tau-PET and longitudinal atrophy differentially; and (b) methodologically, treating heterogeneity (i.e., the different tau-PET patterns) on a continuous scale over a discrete scale can potentially be more efficient for future research. Here, MAPT is linked to Atrophy.